Page last updated: 2024-08-21

2-piperidone and Kidney Failure

2-piperidone has been researched along with Kidney Failure in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Chen, J; Hoffmann, M; Li, Y; Liu, L; MacGorman, K; Palmisano, M; Zhou, S	1
Kim, EY; Kim, N; Kim, YH; Lee, SH; Oh, MK; Park, SJ; Shin, JG; Shon, JH	1

Trials

1 trial(s) available for 2-piperidone and Kidney Failure

Article	Year
Single-Dose Pharmacokinetics, Safety, and Tolerability of Avadomide (CC-122) in Subjects With Mild, Moderate, or Severe Renal Impairment. Clinical pharmacology in drug development, 2020, Volume: 9, Issue:7 Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Carcinoma, Hepatocellular; Case-Control Studies; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Female; Genetic Pleiotropy; Glioblastoma; Hematologic Neoplasms; Humans; Liver Neoplasms; Male; Middle Aged; Piperidones; Quinazolinones; Renal Insufficiency; Safety; Severity of Illness Index; Ubiquitin-Protein Ligases	2020

Article

Year

Single-Dose Pharmacokinetics, Safety, and Tolerability of Avadomide (CC-122) in Subjects With Mild, Moderate, or Severe Renal Impairment.

Clinical pharmacology in drug development, 2020, Volume: 9, Issue:7

Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Carcinoma, Hepatocellular; Case-Control Studies; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Female; Genetic Pleiotropy; Glioblastoma; Hematologic Neoplasms; Humans; Liver Neoplasms; Male; Middle Aged; Piperidones; Quinazolinones; Renal Insufficiency; Safety; Severity of Illness Index; Ubiquitin-Protein Ligases

2020

Other Studies

1 other study(ies) available for 2-piperidone and Kidney Failure

Article	Year
Effect of renal impairment and haemodialysis on the pharmacokinetics of gemigliptin (LC15-0444). Diabetes, obesity & metabolism, 2014, Volume: 16, Issue:10 Topics: Area Under Curve; Creatinine; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Male; Metabolic Clearance Rate; Piperidones; Pyrimidines; Renal Dialysis; Renal Insufficiency	2014